Ben Kukull, MD
@bkukolj.bsky.social
AP/CP, MGP, Med Micro. General and gyn surgical pathologist and lab director. Here for interesting pathology, ID/micro, and molecular oncology. And birds.
Hot off the press. Updated CAP HER2 biomarker templates/guidelines as described for selection of Trastuzumab (modified breast/serous ca criteria) vs Trastuzumab-deruxtecan (gastic/DESTINY trial criteria). Thoughts? Serous vs other? What are your plans? #pathsky
documents.cap.org/protocols/Gy...
documents.cap.org/protocols/Gy...
documents.cap.org
December 12, 2024 at 8:01 PM
Hot off the press. Updated CAP HER2 biomarker templates/guidelines as described for selection of Trastuzumab (modified breast/serous ca criteria) vs Trastuzumab-deruxtecan (gastic/DESTINY trial criteria). Thoughts? Serous vs other? What are your plans? #pathsky
documents.cap.org/protocols/Gy...
documents.cap.org/protocols/Gy...